Active

Celiac

Investor type

VC

Founded

1990

AUM

$15 M

Location

Los Angeles, California, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed

Region of investment

North America
Investor profile last updated: 26 March, 2026

Profile

Celiac disease is one of the world’s most prevalent genetic autoimmune diseases, affecting an estimated 3 million Americans, 70-80% of whom are undiagnosed. Causing the body to attack its own small intestine, it can lead to many other devastating health conditions, including cancer. Unfortunately for the millions who suffer, celiac disease has largely been ignored by our federal government which provides little to no funding for research nor for public awareness of its serious consequences. Through strategic investments in research, education, and advocacy, the Celiac Disease Foundation seeks to remedy this by accelerating treatments and a cure.

The Celiac Disease Foundation, established in 1990, is a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education. Our iCureCeliac® patient registry and extensive patient recruitment services enable us to identify qualified patient candidates and speed their enrollment to advance critical disease research. Our unparalleled advocacy program has led the way to secure federal recognition and first-ever research funding from agencies including the U.S. National Institutes of Health and the Department of Defense. We adhere to the highest scientific and ethical standards as we work each day to promote understanding of celiac disease, empower our patient and provider community, and collaborate with partners and stakeholders to carry our mission forward.

Industry

Biotechnology Business Services (B2B) Digital Healthcare Services HealthTech Medical Devices Life Sciences

Celiac Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Celiac Disease Foundation Impact Fund
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Pre-seed
Seed
North America
$5-10 m
$15 M
March 2026

Contacts

Name
Title
Email
Upgrade to see contacts
avatar
nQrXj5ytxksqiRw0 nQrXj5ytxksqiRw0
nQrXj5ytxksqiRw0
avatar
nQrXj5ytxksqiRw0 nQrXj5ytxksqiRw0
nQrXj5ytxksqiRw0
avatar
nQrXj5ytxksqiRw0 nQrXj5ytxksqiRw0
nQrXj5ytxksqiRw0
avatar
nQrXj5ytxksqiRw0 nQrXj5ytxksqiRw0
nQrXj5ytxksqiRw0
avatar
nQrXj5ytxksqiRw0 nQrXj5ytxksqiRw0
nQrXj5ytxksqiRw0
Investment-team contacts for Celiac — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Celiac

Celiac is a venture capital firm. It backs companies at Pre-seed and Seed, writing tickets of $10-50 m.
Celiac is located in Los Angeles, California, United States.
Celiac was founded in 1990.
Celiac invests in companies and startups in Biotechnology, Business Services (B2B), Digital, Healthcare Services, HealthTech, Medical Devices, Life Sciences.
Celiac invests in companies and startups in North America.
Celiac invests in companies and startups at Pre-seed, Seed.
Celiac usually invests $10-50 m on average.
Celiac has around $15m assets under management.
Celiac last fund was created/launched in 2026-03-18
Celiac can be reached through its website celiac.org, its LinkedIn page and its X account. Its general enquiries address is info@celiac.org. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Celiac — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Celiac directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 26 March, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.